Smruthi Organics has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM), Europe for its product Amlodipine Besilate. The CEP certifies that the quality of the substance complies with the requirements of the European Pharmacopoeia and enables the company to supply this product to pharmaceutical manufacturers in European markets and other regions that recognize the CEP certification. The CEP strengthens the company’s regulatory portfolio and enhances opportunities to expand its presence in regulated markets.
Smruthi Organics is a mid-size, public limited, API manufacturing company from Solapur, India. Its core competency is multi-step organic synthesis and large-scale manufacturing of organic molecules.
